NFL Biosciences SAS (ALNFL)

Currency in EUR
1.33
+0.03(+2.31%)
Closed·
ALNFL Scorecard
Full Analysis
Analysts anticipate sales decline in the current year
ALNFL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.281.34
52 wk Range
1.052.74
Key Statistics
Prev. Close
1.3
Open
1.28
Day's Range
1.28-1.34
52 wk Range
1.05-2.74
Volume
17.35K
Average Volume (3m)
60.37K
1-Year Change
-37.85%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALNFL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.90
Upside
+193.23%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

NFL Biosciences SAS Company Profile

NFL Biosciences SA, a biotechnology company, engages in the development of botanical drugs in France. The company’s pipeline includes NFL-101, a drug candidate for smoking cessation, currently under Phase 2b clinical trials; and NFL-301, a drug candidate for reducing alcohol consumption which is in preclinical stage. It has scientific collaboration with McLean Hospital to deepen the understanding of the mechanism of action of NFL-101, its proprietary botanical drug candidate for smoking cessation. NFL Biosciences SA was incorporated in 2006 and is headquartered in Castelnau-le-Lez, France.

Compare ALNFL to Peers and Sector

Metrics to compare
ALNFL
Peers
Sector
Relationship
P/E Ratio
−8.1x−1.9x−0.5x
PEG Ratio
−0.150.010.00
Price/Book
-1.4x2.6x
Price / LTM Sales
366,393.1x6.5x3.3x
Upside (Analyst Target)
193.2%137.9%43.5%
Fair Value Upside
Unlock5.6%6.8%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 3.90
(+193.23% Upside)

Earnings

Latest Release
Apr 28, 2023
EPS / Forecast
-0.26 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ALNFL Income Statement

People Also Watch

2.2800
ALCPB
+2.47%
3.790
VLS
+5.69%
5.500
ALBDM
+2.61%
252.90
ESLX
+0.28%
60.40
ABVX
-0.33%

FAQ

What Stock Exchange Does NFL Biosciences Trade On?

NFL Biosciences is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for NFL Biosciences?

The stock symbol for NFL Biosciences is "ALNFL."

What Is the NFL Biosciences Market Cap?

As of today, NFL Biosciences market cap is 16.80M.

What Is NFL Biosciences's Earnings Per Share (TTM)?

The NFL Biosciences EPS (TTM) is -0.21.

From a Technical Analysis Perspective, Is ALNFL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has NFL Biosciences Stock Split?

NFL Biosciences has split 0 times.

How Many Employees Does NFL Biosciences Have?

NFL Biosciences has 5 employees.

What is the current trading status of NFL Biosciences (ALNFL)?

As of 09 Aug 2025, NFL Biosciences (ALNFL) is trading at a price of 1.33, with a previous close of 1.30. The stock has fluctuated within a day range of 1.28 to 1.34, while its 52-week range spans from 1.05 to 2.74.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.